Company
United StatesPublic company, NASDAQ: OSUROrasure Technologies, Inc. (NASDAQ: OSUR), Bethlehem, PA – FDA Inspections
Inspection records and compliance data for Orasure Technologies, Inc. in Bethlehem, PA. 1 FDA inspection on record, last inspected August 08, 2024. Publicly traded as NASDAQ: OSUR.
Company Profile
This profile covers Orasure Technologies, Inc. based in Bethlehem, PA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 8, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 8, 2024 | Not classified | Biologics | 1247304 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Orasure Technologies, Inc.
Stock ticker
OSUR
Exchange
NASDAQ
Share price
$3.38
Market cap
$232.8M
Price as of
November 6, 2026
FEI Number
3022474803
Address
2685 Opus Way, Bethlehem, PA 18020-8978, United States
Country
United States
ID: e304eb9b-3349-493b-a471-19f525a3a714